Hematology

The Division of Hematology was founded in 1938 by Carl V. Moore, M.D., and the three main goals established at its inception -- research, teaching and clinical care -- remain in place today.

The Division of Hematology employs full-time faculty members who epitomize excellence in basic and clinical science. The focus of the Division is on non-malignant disorders including diseases of red blood cells, platelets, and the coagulation and fibrinolytic pathways.

News Stories & Tip Sheets:

Showing Stories 1 through 3 of 13.  - Show More

New blood Blood transfusions help children with sickle cell disease and silent strokes Dec. 10, 2007 -- A group of children who have sickle cell disease and who experience silent strokes showed some relief from the silent strokes with blood transfusion therapy, researchers at the School of Medicine have found. The study's results will appear in a future issue of Pediatric Blood and Cancer but are available for review in its advance online publication.

First-of-its-kind procedure Bone marrow transplant performed for sickle cell disease Sept. 25, 2007 -- Bone marrow transplants are best known for their potential to cure people with certain types of cancer. But they also hold promise for people with severe cases of sickle cell anemia, also known as sickle cell disease. Now, in a first-of-its-kind procedure, St. Louis Children's Hospital has performed a bone marrow transplant in a teenager with sickle cell disease, using cells from a donor who is unrelated to him.

Director named Hayashi named director of pediatric hematology/oncology division May 14, 2007 -- Robert J. Hayashi, M.D., has been named director of the Division of Pediatric Hematology/Oncology in the Department of Pediatrics at Washington University School of Medicine. A member of the faculty at the School of Medicine since 1992, Hayashi is an associate professor of pediatrics.

Showing Stories 1 through 3 of 13.  - Show More

Faculty Experts:

Showing 1 Experts.

John DiPersio Chief of the Division of Bone Marrow Transplantation and Stem Cell Biology DiPersio helped pioneer stem cell transplants and now focuses his research efforts on improving the success of bone marrow and stem cell transplants for the treatment of cancer and disorders of the blood. He is investigating the use of gene therapy to control graft versus host disease that is a main ... Expertise: bone marrow transplantation, leukemia/lymphoma, stem cell transplantation, graft vs. host disease Media assistance: (314) 286-0141 / ericsong@wustl.edu

Showing 1 Experts.

Related News Clips:

Showing 1 Clips.

'Bloodless' surgery offers an alternative to transfusion Detroit Free Press and 1 others June 3, 2004 -- A bloodless medicine program offers alternatives for those who do not want blood, and helps to save the supply for those who need it. "What is going to drive conservation of blood is inventory," said Lawrence Goodnough, M.D., professor of medicine at the School of Medicine. "We're kind of skating along with low inventories." Some people will always need donated blood, Goodnough said. "Who are we saving the blood supply for? For trauma cases or bone marrow transplants or newly diagnosed conditions and people who can't plan ahead." The best candidates for bloodless medicine are patients undergoing scheduled or elective procedures. These allow time to take the patient's blood count and make a treatment plan.